MKI67 and breast carcinoma: In conclusion, our prospective GWAS using 347 patients with breast cancer identified three novel candidate loci, chromosome 4q34.3, 6q12, and 10p13, which were associated with Ki-67 response after preoperative tamoxifen therapy.